Select Past Investments
Select Past Investments
 

Founded in 1984, PharmaNet was a leading global Contract Research Organization (CRO) providing clinical development services, including consulting, Phase I and bioequivalency clinical studies, and Phase II–IV clinical development programs to pharmaceutical, biotechnology, generic drug and medical device companies worldwide. In 2011, inVentiv Health acquired PharmaNet, and in early 2013, renamed the Company inVentiv Health Clinical.

INVESTMENT STRATEGY

​Corporate Turnaround: Recognizing PharmaNet’s potential value, JLL Partners restructured the Company’s cost infrastructure to enhance capacity utilization, implemented a number of cost savings and launched a number of growth initiatives to ensure it realized its full potential.

  
Market Opportunity: 
JLL identified CROs as generating attractive opportunities based on the thesis that pharmaceutical companies will continue to outsource former core capabilities such as manufacturing, R&D, and sales and marketing.